Where I see patients (1)
Selected research
-
Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata.
Journal of the American Academy of Dermatology
-
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.
Journal of the American Academy of Dermatology
-
Evaluating the association of central centrifugal cicatricial alopecia (CCCA) and fibroproliferative disorders.
Dermatology online journal